30 mg

DRUG2 trials

Sponsors

Ultragenyx Pharmaceutical Inc., Medical University Of Lodz

Conditions

Attention-deficit hyperactivity disorderType 1 diabetesosteogenesis imperfecta

Phase 2

LAMAinDiab - lisdexamphetamine vs methylphenidate for pediatric patients with ADHD and type 1 diabetes - a randomized crossover clinical trial.

Active, not recruitingCTIS2023-506862-30-00

Medical University Of LodzAttention-deficit hyperactivity disorder, Type 1 diabetes

Start: 2024-11-24Target: 150Updated: 2025-08-25

Phase 3

An Open-label, Randomized, Active-Controlled, Phase 3 Study of Setrusumab Compared With Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta Types I, III or IV

Active, not recruitingCTIS2023-504196-24-00

Ultragenyx Pharmaceutical Inc.osteogenesis imperfecta

Start: 2023-10-17Target: 27Updated: 2025-11-13